Cargando…
Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. Due to often unspecific disease symptoms, locally advanced or metastatic disease is diagnosed in the majority of all cases. Palliative treatment options comprise of conventional cytotoxic agents, immunotherapy with ch...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612950/ https://www.ncbi.nlm.nih.gov/pubmed/31308774 http://dx.doi.org/10.2147/LCTT.S177618 |